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  ABSTRACT 
DETERMINING THE INTRACELLULAR CONCENTRATIONS OF FLAVONOIDS IN  
MDA-MB-231 CELLS USING HPLC-COUPLED MASS SPECTROMETRY 
by Anh Dang Pham 
Flavonoids are polyphenolic compounds found in a wide variety of plants.  In 
recent years, flavonoids have been found to be beneficial to human health.  Our lab has 
investigated the ability of flavonoids to induce cytotoxicity in human breast cancer cell 
lines.  We have discovered that some compounds can induce cytotoxicity very readily, 
whereas others cannot.  We hypothesized that this difference is attributable to a 
compound’s ability to transverse the cell membrane.  Therefore, we used LC-MS to 
measure the amount of each flavonoid that is able to enter into MDA-MB-231 cells, 
human breast cancer cells.  We tested 14 flavonoids.  MDA-MB-231 cells were plated 
and treated with 100 µM flavonoids for 24 and 48 hr.  After treatment, cells were 
extracted using methanol.  Flavonoids from extracts were characterized and quantitated 
by LC-MS.  We found that intracellular flavonoid concentration increased over time for 
some of the flavonoids.  We could not detect quercetin, myricetin, and catechin in cell 
extracts.  However, quercetin was found to be a moderate inducer of cytotoxicity, 
whereas myricetin and catechin were not.  We found that quercetin dimerized over time 
in the cell medium only in the presence of serum.  The quercetin dimer could not be 
detected in cellular extracts, which suggested that it was unable to cross the membrane.  
Additionally, synthetic quercetin dimer did not induce cell death.  Our results suggest that 
only fresh quercetin killed cells; once quercetin dimerized, it could not induce cell death.
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Introduction 
Cancer is a disease in which cells grow out of control.  These cells become 
cancerous due to damage of their DNA, which ultimately leads to mutations.  They 
continue to reproduce, forming new abnormal cells.  Cancer cells also have the ability to 
invade other tissues in the body.  In the United States, one in eight women will develop 
invasive breast cancer in the course of her lifetime.  Breast cancer death rates are second 
highest, just below lung cancer.  Currently, there are multiple treatments for cancers 
including surgery, radiation therapy, chemotherapy, and complementary medicine.  
However, these therapies do not guarantee a cure and can have many negative side 
effects (http://www.breastcancer.org). 
Flavonoids are compounds originally identified in plants.  The consumption of 
fruits and vegetables introduces flavonoids into the human body.  To date, over 4,000 
different flavonoids have been identified (Ramos, 2007).  Studies show that intake of 
foods containing flavonoids reduces the risk of cancer.  They are responsible for 
numerous biological activities including inhibition of cell growth, inhibition of protein 
kinase activity, inhibition of apoptosis, inhibition of MMP secretion, inhibition of tumor 
cell invasion, and inhibition of adhesion and spreading of cells; flavonoids also have anti-
angiogenic properties (Kanadaswami et al., 2005). 
Our group has been studying the ability of flavonoids to induce cell death in a 
variety of breast cancer cell lines.  The results show that not all are successful.  The 
cytotoxicity results vary for each flavonoid.  We hypothesized that this difference can be 
explained by the amount of flavonoid that permeates the cell.  
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In this study, we used liquid chromatography coupled with mass spectrometry to 
determine the amount of flavonoid within cells after an incubation period.  With the 
resultant data, we correlated intracellular concentration of flavonoids and cytotoxicity 
after incubation. 
  
3	  
	  
Literature Review 
Flavonoids: Structure 
Found in a wide distribution of plants, flavonoids are polyphenolic compounds 
that perform multiple functions.  They are considered members of secondary metabolites 
that are not directly responsible for growth, photosynthesis, reproduction, or any other 
primary function of plants (Ramos, 2007).  They play a role in plant pigmentation and 
provide resistance to bacteria, fungi, viruses, and insects; they also provide tolerance to 
freezing temperatures, salt, and metals (Cohen, Sakihama, & Yamasaki, 2001).  In recent 
years, flavonoids have been found to be beneficial to human health because of their anti-
viral, anti-allergic, anti-platelet, antioxidant, and anti-tumor properties (Ramos, 2007).  
To date, over 4,000 flavonoids have been identified.  They all have the similar general 
structural of diphenylpropanes, C6-C3-C6, two benzene rings joined together by a three-
carbon chain with an oxygen bridge (Fig. 1).  Flavonoids are distinguished from one 
another by the presence of hydroxyl and methyl groups at various carbons (Fig. 2).  
Although these compounds are closely related to each other structurally, they could have 
different biological effects. 
 
Fig. 1. General structure and numbering system of flavonoid. 
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Flavonoids are divided into different classes based on their molecular structures.  
The major groups are flavones, flavonols, flavanones, flavanols, and isoflavones 
(Manach, Williamson, Morand, Scalbert, & Rememsy, 2005).  Representatives of the 
flavones group include apigenin, methyl-apigenin, chrysin, luteolin, and methyl-luteolin.  
Flavones are mainly found in herbs such as celery and parsley.  Compounds in this group 
have a backbone structure of 2-phenyl-1-benzopyran-4-one. 
Flavonols are the largest flavonoid group and include quercetin, methyl-quercetin, 
myricetin, and kaempferol.  The backbone structure of flavonols is 3-hydroxy-2-
phenylchromen-4-one.  They can be found in onions, apples, tomatoes, tea, and red wine.  
This group has been extensively studied because of its prevalence in the human diet 
(Manach et al., 2005). 
The representative flavonoids in the flavanones group are naringenin and methyl-
naringenin.  This group has a backbone structure of 2,3-dihydro-2-phenyl-4H-1-
benzopyran-4-one.  Naringenin and methyl-naringenin can be found in citrus fruits such 
as oranges and grapefruits.  Catechin, a flavonoid in the flavanol group, is abundant in 
chocolate, beans, apples, tea, and red wine.  Flavanols have a 2-phenyl-3,4-dihydro-2H-
chromen-3-ol skeleton.  This structure has two chiral carbons, allowing each flavanol to 
have four different diastereoisomers (Manach et al., 2005). 
 Isoflavones can be found only in soybean-derived products.  Examples include 
daidzein and genistein.  The backbone structure for these isoflavones is 3-phenyl-4H-1-
benzopyr-4-one.  This class is distinct from the other classes because the attachment of 
the B ring is at carbon number 3 instead of 2 on the carbon bridge (Manach et al., 2005). 
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Fig. 2. Structures of flavonoids used in this study. The flavonoids may be hydroxylated at 
position 3, 5, 7, 3’, 4’, and/or 5’. Carbon numbering is indicated on quercetin. 
Flavonoids without sugar molecules attached are called aglycones.  Flavonoids 
with one or more sugar molecules, where attached hydroxyl groups are replaced with 
glycosides, are called flavonoid glycosides.  Most of the flavonoids found in natural 
products have a sugar molecule attached with the exception of catechin (Manach et al., 
2005).  The attachment of glycosides plays an important role in the bioavailability of 
flavonoids to the human body (Hollman, de Vries, van Lee-uwen, Mengelers, & Katan 
1995).  Aside from glycosides, flavonoid hydroxyl groups can be capped with methyl 
groups; these flavonoids are called O-methylated flavonoids or methoxyflavonoids.  The 
attachment of methyl groups can also play an important role in flavonoid cell 
permeability, solubility, and anticancer properties (Walle, 2004). 
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Bioavailability of Flavonoids 
Initially, research presupposed that the absorption of flavonoids into the human 
body through food intake was negligible because most are attached to sugar.  Flavonoid 
aglycones were thought to be the only kind that could pass through the wall of the gut; 
there were no known enzymes in the gut that could cleave the glycoside bonds (Kuhnau, 
1976).  However, more recent studies show that the absorption of quercetin glycosides 
from onions is higher than the absorption of quercetin aglycone in vivo, 52% and 24% for 
quercetin glycosides and quercetin aglycone, respectively (Hollman et al., 1995).  This 
suggests that the glycoside moiety enhances absorption.  A study from Day et al. (1998) 
showed that the absorption of quercetin aglycone from tea is half that of the absorption of 
quercetin glycosides found in onions. 
Flavonoids in the diet are absorbed from the gastrointestinal tract (Crespy et al., 
1999).  Medical flavonoids for cancer treatment can be directly injected into tissue such 
as the skin, lungs, throat, and the vascular system (Ross & Kasum, 2002).  Within the 
intestine, bacterial enzymes remove the glycosides from aglycone, and only 15% of 
flavonoid aglycones are absorbed into epithelial cells and carried to the lymph (Day et al., 
1998; Spencer et al., 1999).  Flavonoids are absorbed into cells by passive diffusion, or 
by the Na± dependent transport ATPase (Sharma, Kaushal, Sareen, Singh, & Bhatia, 
1981).  Then, the lymph carrying flavonoids enters the blood stream near the liver.  
Eighty percent of flavonoids are absorbed by the liver because parts of them are attached 
to the serum albumin (Casley-Smith & Casley-Smith, 1986; Podhajcer, Friedlander, 
&Graziani, 1980).  Within the liver, flavonoids travel to the Golgi apparatus to be 
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degraded oxidatively (Griffiths & Smith, 1972).  However, some have already undergone 
oxidative degradation in the intestine by bacterial enzymes (Winter, Moore, Dowell, & 
Bokkenheuser, 1989).  The products are then released by organic acid transporters into 
the blood (Graefe, Derendorf, & Veit, 1999).  Non-absorbed flavonoids leave the body 
through feces and urine (Choudhury, Srai, Debnam, & Rice-Evans, 1999).  The half-life 
of flavonoids in the body has been estimated to be between 1 and 2 hr.  However, there 
are not enough data to support this estimate (Honcha, Platte, Oesch, & Friedberg, 1995).  
The rate of flavonoid absorption and bioprocessing is still not very well characterized 
(Havsteen, 2005).  Further studies are required to fully understand the bioavailability of 
flavonoids. 
Flavonoids can be absorbed into systemic circulation; however, the concentration 
in vivo is not high enough to fully perform their cellular biological functions.  The main 
reason for low oral bioavailability of flavonoids is the conjugation of the free hydroxyl 
group (Walle, 2004).  Therefore, the methyl groups that cap the free hydroxyl groups 
might play an important role in flavonoid absorption.  Absorption of three unmethylated 
versus methylated flavones in Caco-2 cells was observed by Wen & Walle (2006).  
Methylated compounds permeated cells more extensively than unmethylated compounds.  
Wen et al. attribute this property to higher metabolic stability of methylated compounds.  
The bioavailability between chrysin and 5,7-dimethoxyflavone (5,7-DMF), a similar 
structure to chrysin except for the methyl groups on carbons 5 and 7, was observed in 
vivo in rats.  After 1 hr, only 5,7-DMF was detected in the liver, lungs, kidney tissue, and 
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plasma with peak concentration at 2.3 µM.  Chrysin was not detected in any tissues after 
the first hour (Walle, Kawamori, Wen, Tsuji, & Walle, 2007). 
The Anticancer Activities of Flavonoids 
Many experimental studies have explored the effects of flavonoids on general 
health.  Consumption of foods that contain flavonoids has been shown to reduce the risk 
of some diseases, such as cancer (Ramos, 2007).  High soy diets rich in isoflavones 
inhibit tumor development in animal models (Watson, Jiyang, & Jones, 2000).  
Isoflavones, such as genistein, can also inhibit the promotion or progression of cancer by 
removing damaged or initiated cells.  Flavones have been shown to reduce human colon 
carcinoma cell line proliferation (Wenzel, Kuntz, & Brendel, 2000).  Flavonols such as 
quercetin and kaempferol can decrease lipogenesis in prostate and breast cancer cells 
(Brusselmans, Vrolix, Verhoeven, & Swinnen, 2004).  Phenolic compounds have been 
demonstrated to induce apoptosis (Ramos, Alia, Bravo, & Goya, 2005).  However, these 
biological activities are still not very well characterized. 
Flavonoid anticancer activities include inhibition of cell growth, inhibition of 
protein kinase activities, inhibition of apoptosis, inhibition of MMP secretion, inhibition 
of tumor cell invasion, and inhibition of adhesion and spreading of cells; flavonoids also 
have anti-angiogenic properties (Kanadaswami et al., 2005).  Protein kinases are required 
for the proliferation of cancer cells.  Flavonoids have been reported to inhibit three major 
kinases: protein kinase C (PKC), epidermal growth factor receptor (EGFR), and focal 
adhesion kinase (FAK).  Quercetin is the most efficient inhibitor of PKC, and PKC plays 
a role in cell multiplication, apoptosis, and transformation (Gamet-Payrastre et al., 1999).  
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Quercetin and luteolin have been demonstrated to be the most active inhibitors of 
partially purified rat brain PKC.  Luteolin competitively blocks the ATP binding site on 
the catalytic unit of PKC (Ferriola, Cody, & Middleton, 1989).  EGFR tyrosine kinase is 
a cell surface glycoprotein that binds EGF, and EGF stimulates the growth of tumor cells 
(Carpenter & Cohen, 1990).  If the amount of EGFR tyrosine kinase activity was 
reduced, tumor cell growth would be inhibited (Lee et al., 2002).  Genistein, luteolin, and 
quercetin have also been shown to suppress EGFR tyrosine kinase activity (Constantinou, 
Kiguchi, & Huberman, 1990; Lee et al., 2002).  FAK is an important regulator of the cell-
signaling pathway for cell survival, cell cycle, and cell mobility (Schlaepfer, Hauck, & 
Sieg, 1999).  In tumor cells, FAK is overexpressed; inactivation of FAK suppresses cell 
proliferation and mobility.  Tumor cells treated with luteolin and quercetin exhibit a 
reduction of FAK expression (Lee et al., 2004). 
Apoptosis, programed cell death, plays an important role in embryonic 
development, metamorphosis, hormone-dependent atrophy, and maintenance of tissue 
homeostasis (Kanadaswami et al., 2005).  Apoptosis is one of the pathways used by 
antitumor agents to stop the growth of tumor cells.  Flavonoids have been shown to 
induce apoptosis.  Moreover, genistein, quercetin, and luteolin have been shown to 
induce apoptosis in the HL-60 cell line (Huang et al., 1999; Traganos, Ardelt, Halko, 
Bruno, & Darzynkiewicz, 1992; Wei et al., 1994).  In leukemia HL-60 cells, genistein 
caused apoptosis within 8 hr.  EGF, TGF-α, and basic fibroblast growth factor, which 
have the ability to suppress apoptosis, were completely blocked by genistein (Tilly, 
Billig, Kowalski, & Hsueh, 1992).  Quercetin has the ability to induce apoptosis by 
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inhibiting the synthesis of heat shock protein (Wei et al., 1994).  Quercetin and luteolin 
significantly induce apoptosis in MiaPaCa-2 cells by blocking the EGFR-signaling 
pathway (Kanadaswami et al., 2005).  Huang et al. (1999) showed that quercetin and 
luteolin induced apoptosis in tumor cells such as A431, MiaPaCa-2, Hep G2, and MCF 7.  
At low concentrations, 15-25 µM, luteolin was able to slow the growth of A431 and 
MiaPaCa-2 by oligonucleosomal DNA cleavage, cytoplasmic blebbing, and PARP 
degradation. 
The worst danger of cancer disease is that it has the ability to metastasize, 
spreading of cancer from one organ to another (Liotta, Steeg, & Stetler-Stevenson, 1991).  
The invasion of cancer cells correlates with the production of certain matrix 
metalloproteinases (MMPs) (Liabakk, Talbot, Smith, Wilkinson, & Balkwill, 1996).  
MMPs degrade the components of the extracellular matrix.  Cancer cells require MMPs 
to degrade extracellular enzymes to cross the tissue barriers they encounter.  Flavonoids 
have been studied as agents that down-regulate the biosynthesis of MMPs (Kim, 2003).  
Through the PKC pathway, quercetin was able to decrease pro-MMP-9 in a dose-
dependent manner by blocking phorbol-12,13-diutyrate, a PKC activator (Zhang, Huang, 
& Xu, 2004).  In A431 cells, both quercetin and luteolin were able to decrease the 
secretion of MMP-2 and MMP-9 (Huang et al., 1999).  In vitro, MDA-MB-231 MMP-9 
activity was down-regulated by genistein; therefore, the invasion of MDA-MB-231 was 
inhibited (Magee, McGlynn, & Rowland, 2004).  Apigenin, quercetin, and luteolin have 
shown the ability to inhibit MMP-2 and MMP-9.  Moreover, flavonoids with more 
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hydroxyl groups or glucoside groups inhibited the effect of MMP-2 and MMP-9 at a 
higher rate (Ende & Gebhardt, 2004). 
Cellular Uptake of Flavonoids 
The uptake of flavonoids into cells may help determine their biological action.  
The rate of flavonoid uptake in vivo is dependent on cell type, intracellular metabolism, 
and rate of export (Spencer, Mohsen, & Rice-Evans, 2004).  A precise measurement of 
flavonoid uptake by cells is very hard to determine.  Flavonoids can either enter a cell or 
interact with extracellular receptors.  Current extraction protocols cannot precisely 
measure the amount of flavonoid within the cytosol or on the cell membrane because the 
protocols cannot differentiate between these two possibilities (Spencer et al., 2004). 
Various flavonoids were observed for the degree of cellular uptake in Caco-2 cell 
monolayers in HBSS and DMEM.  Cells were treated with 50 µM flavonoids including 
myricitrin, rutin, isoquercitrin, quercetin, myricetin, kaempferol, luteolin, and apigenin 
for 2 hr.  Viable cells were extracted by methanol, and the flavonoids in cellular extracts 
were quantified by HPLC.  The degree of flavonoid uptake was different between media 
used for cell incubation.  In HBSS, the order of uptake was quercetin = kaempferol = 
luteolin > apigenin.  In DMEM, the order of uptake was kaempferol > luteolin = apigenin 
> quercetin.  Myricitrin, rutin, isoquercitrin, and myricetin were not detected in cell 
extracts.  Cells did not absorb glycosides such as myricitrin, rutin, and isoquercitrin.  The 
authors suggest that glycosides must be metabolized to be sufficiently absorbed by cells.  
Myricetin, an aglycone, was not detected in cell extracts; this might have been because of 
its instability as it rapidly degraded in both media.  The degree of flavonoid uptake was 
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dependent on both incubation time and concentration in both media.  Flavonoids were 
incorporated into cells rapidly in the first 30 min after incubation; the incorporating rate 
was then reduced.  The degree of flavonoid uptake in HBSS was approximately four 
times higher than in DMEM (Yokomizo & Moriwaki, 2006). 
In addition, Caco-2 cells were able to uptake epicatechin, epigallocatechin gallate, 
and quercetin-3-glucoside after 24 hr.  Studies with epicatechin showed that 24 hr after 
incubation, 0.43 ng/106 cells was detected, and the uptake increased to 3.5 ng/106 cells at 
72 hr.  The uptake of epicatechin increased over incubation time; however, 
epigallocatechin reached the maximum level at 48 hr.  Meanwhile, quercetin-3-glucoside 
was not detected after a 72-hr incubation.  The authors proposed that cells did not take up 
quercetin-3-glucoside because it was more polar (Salucci, Stivala, Maiani, Bugianesi, & 
Vannini, 2002). 
Another case of quercetin uptake was investigated in the human hepatocarcinoma 
cell line, HepG2.  These cells accumulated quercetin 9.6-fold and exhibited the formation 
of a 3’-O-methylated metabolite.  However, after 8 hr, quercetin was no longer detected.  
The authors suggest that quercetin was extensively metabolized (Watanabe et al., 2001). 
The rate of flavonoid cell uptake in vitro may not be similar to uptake in vivo.  In 
vitro, cells grow in a monolayer form; as such, they can be exposed more to the 
flavonoids in the cell culture medium.  In vivo, the amount of flavonoid exposed to cells 
might not be as high as in vitro because of tight growing surface in the cellular 
environment (Spencer et al., 2004). 
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Flavonoid Oxidation 
In plant tissue, quercetin can undergo oxidation by oxidative enzymes such as 
polyphenol oxidase (PPO) and peroxidase (POD) to form three major oxidative products 
(Gulsen et al., 2007).  The same oxidation can be generated in vitro with potassium 
ferricyanide under alkaline conditions (Makris & Rossiter, 2002).  Under these 
conditions, a high amount of oxidation product was generated, forming a quercetin dimer.  
This oxidation product was analyzed under positive ion mode LC-MS and has an m/z of 
603 [M + H]+.  A possible mechanism proposed for quercetin oxidation is shown in 
Figure 3.  The quercetin oxidation by potassium ferricyanide generated the same set of 
products compared with the oxidation of quercetin by mushroom PPO and horseradish 
POD.  During the oxidation process of several flavonoids, only the B ring was affected.  
If the hydroxyl groups on the B ring were methylated, there was no reaction (Fig. 3).  In 
vitro, flavonoids readily undergo oxidation in cell culture medium.  However, in vivo, 
oxidation of flavonoids may be limited because of low oxygen tension in the cellular 
environment (Pelter, Bradshaw, & Warren, 1971). 
 
Fig. 3 Proposed mechanism of quercetin oxidation. During the oxidation process, only 
the hydroxyl groups on B ring are involved. If the hydroxyl groups are methylated, 
oxidation cannot proceed (Krishnamachari, Levine, & Pare, 2002). 
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Liquid Chromatography and Mass Spectrometry in Flavonoid Studies 
Mass spectrometry is useful in the detection of compounds in a solution.  It is a 
very powerful tool that has high sensitivity and provides accurate molecular mass 
(Cuyckens & Claeys, 2003).  A German physicist, Wilhelm Wien, developed the 
foundation of mass spectrometry in 1899.  He constructed an instrument that could 
separate compounds based on their charge-to-mass ratio using electric and magnetic 
fields (de Hoffmann & Stroobant, 2004).  In 1912, a British physicist, Sir Joseph John 
Thomson, modified Wien’s foundation and created one of the first mass spectrometry 
instruments to separate neon isotopes by their masses.  Recently, mass spectrometry has 
become popular in biological applications.  More mass spectrometry invention and 
improvements have been acknowledged in the science field.  In 2002, John Bennett Fenn 
received the Nobel Prize in Chemistry for his development of electrospray ionization 
(ESI).  In the same year, Koichi Tanaka received the Nobel Prize in Chemistry for the 
development of soft laser desorption. 
In this thesis, the data were acquired from liquid chromatography-mass 
spectrometry (LC-MS).  Liquid chromatography coupled with mass spectrometry has 
been a popular method used to study these small molecules because of its sensitivity and 
accuracy (Plazonic et al., 2009).  It is a process that involves compounds that are 
dissolved in solution (mobile phase) that are passed through a stationary phase which 
seperates the compounds based upon a particular property.  The stationary phase we have 
used is known as a reverse-phase which separates compounds based upon polarity.  
Flavonoids have different affinities to reverse-phase columns based on their polarity.  
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More polar flavonoids elute earlier than less polar ones.  Because most have different 
polarities, they can be separated for analysis by a mass spectrometer (Fig. 4).  After 
chromatography separation, the molecules are introduced directly into a mass 
spectrometer, a tool that consists of an ion source, mass analyzer, and a detector.  
 
Fig. 4. Flavonoids separation by liquid chromatography. X axis: retention time (min), Y 
axis: relative abundance. See method section for mobile and stationary phase. Cat: 
catechin, Myr: myricetin, Dai: Daidzein, Lut: luteolin, Quer: quercetin, Nar: naringenin, 
Kaemp: kaempferol, Api: apigenin, M-Quer: methyl-quercetin, Chrys: chrysin, M-Lut: 
methyl-luteolin, M-Nar: methyl-naringenin, M-Api: methyl apigenin. 
Electrospray ionization and matrix-assisted laser desorption/ionization are the two 
most common ion sources.  In this project, electrospray ionization was the choice for the 
ion source.  The sample from the liquid chromatography, which contains the molecule(s) 
of interest, is in liquid form.  It is then sprayed through a small capillary into a strong 
electric field, which adds a charge to each droplet.  The charged droplets are sampled into 
the vacuum stage of the instrument.  The drying gas is used to evaporate the solvent from 
these droplets to create lone ions (Fenn, Mann, Meng, Wong, & Whitehouse, 1989).  ESI 
can apply either a positive or negative charge on the droplet.  For positive-ion mode, 
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formic acid is usually added to the solvent to enhance protonation.  For negative-ion 
mode, ammonium formate is used to enhance deprotonation.  Positive-ion mode was used 
in this project. 
The mass analyzer is the second part of a mass spectrometer.  Molecules will be 
measured by their mass-to-charge ratio.  A good mass analyzer must be sensitive, 
possessing both mass resolution and mass accuracy (Aebersol & Mann, 2003).  There are 
different types of mass analyzers such as time-of-flight (TOF), quadrupole, fourier 
transform ion cyclotron, and the orbitrap mass analyzer.  In this project, we used TOF 
and quadrupole mass analyzers.  The quadrupole is used as a filter to help sort different 
ions.  It consists of four parallel rods to which voltage is applied.  As charged molecules 
leave the ion source, they travel through these rods; only certain molecules will not 
collide with the rods and reach the other side.  Depending on the voltage applied to the 
rods, molecules of a specific mass-to-charge ratio can be filtered.  As the molecules leave 
the quadrupole mass analyzer, they enter the TOF mass analyzer.  This analyzer uses an 
electrical field to accelerate these charged molecules through a path.  It measures the 
mass of the molecules based on how long it takes for them to reach the detector.  
Molecules with larger mass reach the detector later than smaller ones. 
As molecules leave the TOF mass analyzer they impact with a detector, a metal 
plate.  Electrons on this plate will neutralize the charge of the molecules.  The 
neutralization is detected and recorded for mass and abundance data. 
The Agilent Technologies 6520 Q-TOF mass spectrometer can accurately detect 
masses of flavonoids up to four decimal places and has mass accuracy of two to five parts 
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per million.  Most of the flavonoids tested have distinguishable masses (Table 1).  
Combining the specific retention time from the HPLC and the distinguished masses from 
the mass spectrometer, the amount of flavonoids can be detected and quantified in a 
solution.  Mass spectrometry only gives a relative abundance of a flavonoid in a solution.  
It does not provide the exact concentration of the molecule.  However, with a set of 
standards, flavonoids can be accurately quantified from a solution. 
Table 1. Flavonoids with specific molecular formulas and masses.  
Flavonoids Molecular Formula Exact Mass (g/mol) m/z [M+H] 
Apigenin C15H10O5 270.0528 271.0601 
Methyl-Apigenin C18H16O5 312.0998 313.1071 
Catechin C15H14O6 290.0790 291.0863 
Chrysin C15H10O4 254.0579 255.0652 
Daidzein C15H10O4 254.0579 255.0652 
Genistein C15H10O5 270.0528 271.0601 
Kaempferol C15H10O6 286.0477 287.0550 
Luteolin C15H10O6 286.0477 287.0550 
Methyl-Luteolin C19H18O6 324.1103 343.1176 
Myricetin C15H10O8 318.0376 319.0448 
Naringenin C15H12O5 272.0685 273.0757 
Methyl-Naringenin C18H18O5 314.1154 315.1227 
Quercetin C15H10O7 302.0427 303.0499 
Methyl-Quercetin C20H20O7 372.1209 373.1282 
Quer-3-O-GP C21H20O12 464.0954 465.1028 
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Flavonoids Induce MDA-MB-231 Cell Death 
Our group has characterized the ability of a group of flavonoids to induce 
cytotoxicity in a variety of breast cancer cell lines.  We determined the IC50 values for 
flavonoids after 72 hr of treatment and reported the results for the MDA-MB-231 cell line 
(Table 2).  The results show that not all flavonoids are able to induce cytotoxicity.  
However, for those that are, the IC50 values vary (Yadegarynia et al., 2012). 
Table 2. IC50 values for flavonoids after 72 hr incubation with MDA-MB-231 cells. 
Values are reported as µM. Numbers in parenthesis are the range for 95% confidence 
interval. 
 
  
Flavonoid IC50 (95% CI) 
Apigenin 14 (11-19) 
M-Apigenin 33 (27-40) 
Catechin >200 
Chrysin 40 (35-45) 
Daidzein 179 (144-222) 
Genistein 51 (43-61) 
Kaempferol 38 (31-47) 
Luteolin 16 (14-20) 
M-Luteolin 21 (12-38) 
Myricetin >200 
Narigenin >200 
M-Narigenin 75 (59-96) 
Quercetin 101 (82-124) 
M-Quercetin 54 (39-75) 
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Method 
Materials and Equipment 
Flavonoids were purchased from Indofine Chemical Co.  Stocks were prepared in 
100% dimethyl sulfoxide (DMSO) at 50 mM and stored at -20oC.  MDA-MB-231 cells 
were purchased from American Type Culture Collection.  Cells were grown in 
Dulbecco’s Modification of Eagle’s Medium (DMEM) with 10% (v/v) fetal bovine 
serum (FBS) and 1% (v/v) antibiotics, penicillin and streptomycin (referred to as 
complete medium), at 37oC and 5% CO2 in a humidified environment.  DMEM with high 
glucose, L-glutamine, and sodium pyruvate were purchased from Cellgro.  Antibodies 
and FBS were purchased from Hyclone. 
HPLC-grade H2O, acetonitrile (ACN), and methanol (MeOH) were purchased 
from Fisher Scientific.  An Agilent Technologies 1100 HPLC was coupled to an Agilent 
Technologies Q-TOF LC-MS 6520 mass spectrometer.  For data acquisition and analysis, 
the software packages used were Agilent Masshunter Workstation, Agilent Masshunter 
Qualitative, Agilent Masshunter Quantitative, and Agilent MassProfiler. 
Cell Cytotoxicity of Flavonoids 
MDA-MB-231 cells were plated at a density of 3 x 106 cells/plate in 10 cm 
dishes.  After 24 hr, the medium was removed from the dishes.  Cells were washed with 3 
ml of phosphate buffered saline (PBS).  New medium with 100 µM flavonoid was added 
to the dishes; DMSO was added as control.  After 24 and 48 hr, the medium was removed 
from the dishes, and cells were washed with 3 ml of PBS.  To remove the cells, 3 ml of 
trypsin was added, and cells were incubated for 2 min.  Both trypsin and cells were 
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collected into 15 ml conical tubes.  Another 7 ml of PBS was used to ensure the cells 
were completely washed from the plate.  The washed cells were combined into conical 
tubes, which were then centrifuged at 1500 rpm for 5 min.  Supernatants were removed.  
Cells were resuspended and mixed in 5 ml of PBS.  To determine the cell viability, 10 µl 
of cells were mixed with 10 µl of Trypan Blue.  Cell viability was determined using a 
Bio-Rad TC10 Automated Cell Counter.  The viability percentages were normalized to 
the DMSO treatment. 
Cell viability of fresh quercetin solution and 24 hr-old quercetin solution were 
compared.  Cells were plated at 5 x 106 cells/dish in complete medium.  For one set, cells 
were treated with new medium with fresh 100 µM quercetin.  For the other set, cells were 
treated with 24 hr-old 100 µM quercetin medium.  Cell viability was determined 24 hr 
after incubation.  The viable percentages were normalized to the DMSO treatment.  For 
control purposes, this experiment was repeated with kaempferol. 
 Cell viability of single-dose treatment and multiple-dose treatment of quercetin 
were compared.  Cells were plated at 5 x 105 cells per well in six-well dishes in complete 
medium.  For single-dose treatment, cells were treated once with 100 µM quercetin 
medium.  For multiple-dose treatment, cells were treated three times with 100 µM 
quercetin medium.  At hour 0, 6, and 12, old medium was removed, and new 100 µM 
quercetin medium was added.  The cytotoxicity was determined at 72 hr after the initial 
incubation.  The viable percentages were normalized to the DMSO treatment.  For 
control purposes, this experiment was repeated with kaempferol. 
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Cellular Uptake of Flavonoids 
After performing cell viability counts, the remaining cells were centrifuged at 
1500 rpm for 5 min.  Supernatants were removed.  To extract flavonoids, 5 ml of 40% 
MeOH with 0.1% (v/v) formic acid was added to cells, which were mixed and placed on 
ice for 15 min.  Cells were then centrifuged at 1500 rpm for 5 min.  Supernatants were 
collected for LC-MS analysis.  To ensure all flavonoids were extracted from cells, 
another 1 ml of 40% MeOH with 0.1% (v/v) formic acid was added to the cell pellet and 
resuspended, transferred into microcentrifuge tubes, and placed on ice for 15 min.  Cells 
were centrifuged at 14,000 rpm for 5 min, and supernatants were collected for LC-MS 
analysis. 
The extraction volume of 5 ml and 1 ml of 40% MeOH was enough to extract 
99% of flavonoids from cells (Table 3).  The first 5 ml of 40% MeOH extracted out 
94.8% of the total flavonoids.  The second 1 ml of 40% MeOH extracted out 4.4% of the 
total flavonoids.  The third 1 ml of 40% MeOH extracted out 0.8% of the total 
flavonoids, which was determined to be negligible.  Therefore, we chose the 5 ml and 1 
ml of 40% MeOH for flavonoid extraction from viable cells. 
Table 3. Methanol extraction volume. The first 5 ml of 40% MeOH extracted out 94.8%, 
and the next 1 ml of 40% MeOH extracted out 4.4% of total flavonoid extracted from 
viable cells. 
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LC-MS Parameters 
An Agilent Technologies 1100 HPLC was coupled to an Agilent Technologies Q-
TOF LC-MS 6520 for data acquisition.  Flavonoids were separated with a Cogent 
Bidentate C18 column, a reverse stationary phase with spherical shaped thermally treated 
Type C Silica (150 mm x 2.1 mm I.D., 4 µm particle size).  The column was held at 
30oC.  A binary mobile phase system of solvent A (water and 0.1% (v/v) formic acid) and 
solvent B (acetonitrile with 0.1% (v/v) formic acid) with a flow rate of 0.5 ml/min 
provided the best separation using the following gradient: 30% B was held for 2 min; a 
linear ramp increased B to 95% from 2 to 10 min; 95% B was held until 11 min; a linear 
ramp decreased B to 5% from 11 to 12 min; from 12 to 13 min, B was increased to 95% 
then decreased to 30% at minute 14 (Fig. 5). The sample injection volume was 1 µl. 
 
Fig. 5. The HPLC gradient of sample separation using Cogent Bidentate C18 column. A: 
Water and 0.1% formic acid, B: acetonitrile and 0.1% formic acid. 0-2 min: 30% B, 2-10 
min: increased to 95% B, 11-12 min: decreased to 5% B, 12-13 min: increased to 95% B, 
13-14 min: decreased to 30% B. 
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After separation, the compounds were ionized for mass spectrometry detection by 
positive ion electrospray ionization.  The mass spectrometer was set with the following 
conditions: gas temperature, 350oC; drying gas rate, 8 liters of liquid nitrogen/minute; 
nebulizer, 350 psig; fragmentor voltage, 150 V; skimmer voltage, 65 V; acquisition rate, 
1.03 spectra/s. 
Flavonoid Standard Curve Preparation 
The mass spectrometer provided only the relative abundance of the flavonoid 
detected in the extracts, not the exact concentration.  To determine the concentration of 
flavonoid detected from the extracts, we created standard curves for each individual 
flavonoid. 
Each purified flavonoid was prepared in a series of dilutions: 75 µM, 50 µM, 10 
µM, 1 µM, and 0.1 µM in 40% MeOH.  To make the 75 µM standard, 7.5 µl was drawn 
from a 50 mM stock flavonoid solution and mixed with 5000 µl of 40% MeOH.  From 
the 75 µM standard, 1000 µl was drawn and mixed with 500 µl of 40% MeOH to make a 
50 µM standard.  Next, 200 µl was drawn from the 50 µM standard and mixed with 800 
µl of 40% MeOH to make a 10 µM standard. Next, 100 µl was drawn from the 10 µM 
standard and mixed with 900 µl 40% MeOH to make a 1 µM standard. Lastly, 100 µl was 
drawn from the 1 µM standard and mixed with 900 µl 40% MeOH to make a 0.1 µM 
standard.  From each standard, 1 µl was injected onto the LC-MS to obtain the 
abundances detected for 75, 50, 10, 1, and 0.1 pmol of flavonoid.  An equation in a form 
of y = mx + b was obtained using Agilent Masshunter Quantitative software, where the y 
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axis represented the number of responses from the abundances of the standards, and the x 
axis represented the pmol in the standards (Fig. 6). 
 
 
Fig. 6. An example of flavonoid standard curve. Different concentrations of daidzein 
were used to generate the standard curve; y axis: responses from the abundance of the 
standards; x axis: pmol of the standards. Y = 25734.925777 x – 571.376612. 
 
Flavonoid Concentration Calculation From Cell Extract 
 After injecting the cell extracts onto the LC-MS, the data obtained were the 
number of responses detected from the abundance of the flavonoid within cells.  The 
Agilent Masshunter Quanttative software used the y = mx + b from the standard curve to 
determine the exact concentration of flavonoid in the cell extract (Table 4). 
 
75	  pmol 
50 
10 
1 
0.1 
y=25734.925777	  (x)	  –	  571.376612 
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Table 4. An example of data collected from daidzein treatment at 48 hr. The first column 
represents the names of the sample. The RT column represents the retention times of the 
flavonoid. The Resp. column represents the abundances detected. The Calc. conc. column 
represents the final concentrations of the flavonoids detected. 
 
 
Table 4 is an example of how the flavonoid concentration was calculated.  The 
first five rows are the data for the standard samples.  The next seven rows are the data for 
the cell extracts.  Data were obtained in triplicate. Column 1 shows the names of the 
samples.  The data from samples 3a1, 3b1, and 3c1 are from the first extraction (5 ml of 
40% MeOH) from three different plates.  The data from samples 3a2, 3b2, and 3c2 are 
from the second extraction (1 ml of 40% MeOH).  This was described in the cell extract 
methodology above. 
In the first extraction from sample 3c, after 1 µl of sample was injected, 
0.3395642 pmol of daidzein was detected.  The total extraction volume for the first 
extraction of 3c sample was 5000 µl.  Therefore, the total pmol extracted from the first 
extraction was 0.3395642 pmol x 5000 µl = 1697.821 pmol.  In the second extraction 
  Daidzein Method Daidzein Results 
Name Data File Type Level Exp. Conc. RT Resp. Calc. Conc. Accuracy 
Dai 0.1 Daid 0.1uM C18 062411.d Cal 1 0.1 2.047 1399.0627 0.09968589 99.68589 
Dai 1 Daid 1uM C18 062411.d Cal 2 1 1.962 28092.613 0.99992733 99.99273 
Dai 10 Daid 10uM C18 062411.d Cal 3 10 1.994 290503.92 10.048271 100.4827 
Dai 50 Daid 50uM C18 062411.d Cal 4 50 1.984 1317608.7 49.8477416 99.69548 
Dai 75 Daid 75uM C18 062411.d Cal 5 75 1.973 1862062.2 75.1090788 100.1454 
DMSO DMSO 48hr 062311.d Sample    1.428 209.04212 0.05963543  
3a2 D100 3A2 48hr 062311.d Sample    2.102 2136.0161 0.1244918  
3b2 D100 3B2 48hr 062311.d Sample    2.075 3172.6149 0.15938838  
3c2 D100 3C2 48hr 062311.d Sample    2.169 2401.1256 0.10341607  
3a1 D100 3A1 48hr 062311.d Sample    1.951 7875.2618 0.317768  
3b1 D100 3B1 48hr 062311.d Sample    1.969 9925.052 0.38683713  
3c1 D100 3C1 48hr 062311.d Sample    2.035 8167.2828 0.3395642  
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from sample 3c, after 1 µl of sample was injected, 0.1034607 pmol of daidzein was 
detected.  The total extraction volume for the second extraction of 3c was 1000 µl.  
Therefore, the total pmol extracted from the second extraction was 0.1034607 pmol x 
1000 µl = 103.41607 pmol.  After two extractions, the total pmol extracted from viable 
cells were 1697.821 + 103.41607 = 1801.23707 pmol.  In this experiment, the total 
number of viable cells at 48 hr after treatment with daidzein 100 µM was 7,100,000 cells.  
Therefore, the amount of daidzein extracted from one viable cell was 1801.23707 
pmol/7,100,000 cells = 2.537 x 10-4 pmol/cell. 
Similar calculations were performed for all other flavonoids in this study.  The 
average and standard deviations were taken from the triplicate. 
Flavonoid Stability in Complete Medium 
A 100 µM flavonoid solution was prepared in 5 ml of complete medium.  The 
medium with flavonoid was incubated at 37oC and 5% CO2 in a humidified environment.  
At both time points, 0 and 24 hr, the medium was mixed and 600 µl was drawn into a 
microcentrifuge tube.  The medium was then mixed with 400 µl of 100% MeOH.  The 
sample was mixed and placed on ice for 15 min, then centrifuged at 14,000 rpm for 10 
min to pellet precipitated salt and protein.  Supernatant was collected and 1 µl was 
injected into LC-MS for analysis. 
Detection of Quercetin Dimer using Agilent MassProfiler Software 
Quercetin was prepared in complete medium at the concentration of 100 µM and 
incubated in the cell-tissue-culture incubator.  Quercetin was extracted in 40% MeOH at 
0, 6, and 24 hr.  At each time point, the sample was mixed and placed on ice for 15 min.  
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The sample was centrifuged at 14,000 rpm for 10 min to remove precipitated salts and 
proteins.  Supernatant was collected and 1 µl was injected into LC-MS for analysis.  
Agilent MassProfiler software was used to detect any changes in mass and abundance 
from different time points. 
Detection of Quercetin Dimer in the Presence of Fetal Bovine Serum 
Two solutions were used to monitor quercetin dimerization, PBS with 10% (v/v) 
normal FBS and PBS with 10% (v/v) boiled FBS.  For PBS with 10% normal FBS, 1 ml 
of FBS was added to 9 ml of PBS, and quercetin was added to 100 µM.  For PBS with 
10% boiled FBS, 2 ml of FBS were first boiled for 10 min, then, 1 ml of boiled FBS was 
added to 9 ml of PBS and quercetin was added to 100 µM.  Both solutions were 
incubated at 37oC, 5% CO2 in a humidified environment.  Samples were extracted at 0 
and 24 hr in 40% MeOH after incubation.  The samples were mixed and placed on ice for 
15 min.  They were then centrifuged at 14,000 rpm for 10 min to pellet precipitated salts 
and proteins.  Supernatants were collected and 1 µl of each sample was injected into LC-
MS for analysis.  Quercetin and quercetin dimer, M+H 303.0499 m/z and 603.0769 m/z, 
respectively, were measured for analysis at both 0 and 24 hr. 
Detection of Quercetin Dimer in the Presence of BSA and Actin 
Quercetin was mixed in PBS with two different proteins, BSA and actin.  For 
negative control, quercetin was mixed in 1000 µl of PBS to 100 µM.  For PBS with BSA, 
2.5 mg of BSA were mixed with 1000 µl PBS and quercetin was added to 100 µM.  For 
PBS with actin, 2.5 mg of actin were mixed with 1000 µl PBS and quercetin was added 
to 100 µM.  Three different sets of tubes were prepared; each was incubated at a different 
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temperature: 22oC, 4oC, and 37oC.  At each time point, hour 0, 6, and 24, 200 µL of 
sample were drawn into microcentrifuge tubes and 150 µl of 100% MeOH were added to 
achieve 42% MeOH in the final solution.  The tubes were mixed and placed on ice for 15 
min.  The tubes were centrifuged at 14,000 rpm for 10 min.  Supernatants were collected 
and injected into LC-MS for analysis. 
Quercetin Dimer Synthesis and Isolation 
Quercetin dimer can be synthesized from quercetin oxidation with potassium 
ferricyanide (Gulsen et al., 2006).  Three hundred forty milligrams of quercetin were 
mixed with 80 ml of acetonitrile.  At room temperature, a 20 ml solution of 50 mM 
potassium ferricyanide and 50 mM sodium carbonate was added dropwise over 30 min 
under continuous stirring.  The potassium ferricyanide, sodium carbonate, and quercetin 
final concentration was 10 mM.  The solution was stirred for another 3 hr in the dark.  
Concentrated hydrochloric acid was used to adjust the pH to 2.  The solution was 
concentrated under vacuum until all of the acetonitrile was removed.  Forty milliliters of 
ethyl acetate:diethyl either (8:2 v/v) solution were added to extract the solution.  The 
solution was extracted four times.  Water was removed by adding magnesium sulphate; 
the solution was then filtered and evaporated by rotary evaporation.  The final product 
was verified using silica thin layer chromatography (TLC) and mass spectrometry to 
detect the presence of quercetin dimer. 
The solvent for TLC was methanol:dichloromethane (1:9 v/v).  The TLC’s zone 
with quercetin dimer product was isolated and eluted out with 5 ml of 
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methanol:dichloromethane (2:8 v/v).  The solution was concentrated under vacuum. 
NMR and mass spectrometry verified the final quercetin dimer solution. 
Statistical Analysis 
For comparison between two groups in all other assays, the data were analyzed 
using the two-sided, two independent sample Student t-test with 95% confidence 
intervals reported.  A p-value of p<0.05 was regarded as statistically significant. 
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Results 
Flavonoids Cytotoxicity on MDA-MB-231 Cells after 24 and 48 hr 
Fourteen different flavonoids were used at 100 µM (luteolin was used at 50 µM) 
on MDA-MB-231 cells, and cell viability was determined after 24 and 48 hr.  Cell 
viability percentages were normalized to the DMSO treatment.  This viability decreased 
with time for all flavonoids except for catechin, myricetin, and m-naringenin.  
Kaempferol and luteolin had the strongest effect in decreasing cell viability (Fig. 7).  
These results are consistent with those of Sina Yadegarynia (2012), which reported cell 
viability for 72 hr. 
	  
Fig. 7. Cell viabilities at 24 and 48 hr after treated with flavonoids at a concentration of 
100 µM. Except for luteolin, the concentration was 50 µM. 
 
We grouped the flavonoids based on their ability to decrease cell viability into 
three categories.  Cell viability that was less than 50% was considered a strong killer; cell 
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viability ranging from 50% to 75% was considered a moderate killer; and cell viability 
that was more than 75% was considered a weak killer.  Kaempferol and luteolin were 
most effective at inducing cell death.  At 24 hr, cell viabilities were 46.1% and 37.9% for 
kaempferol and luteolin, respectively.  At 48 hr, cell viable percentages were 16.6% and 
26.4% for kaempferol and luteolin, respectively. Apigenin, methyl-apigenin, and 
quercetin were moderate killers at 24 hr, but strong killers at 48 hr.  At 24 hr, the cell 
viabilities were 64.6%, 61.8%, and 61.3% for apigenin, methyl-apigenin, and quercetin, 
respectively.  At 48 hr, the cell viabilities were 34.3%, 44.6%, and 46.1% for apigenin, 
methyl-apigenin, and quercetin, respectively.  Methyl-quercetin was a moderate killer at 
both 24 and 48 hr.  The cell viabilities for methyl-quercetin were 69.5% and 59.6% at 24 
and 48 hr, respectively.  Chrysin, genistein, methyl-luteolin, and naringenin were weak 
killers at 24 hr and moderate killers at 48 hr.  At 24 hr, the cell viabilities were 95.8%, 
80.8%, 90.89%, and 82.2% for chrysin, genistein, methyl-luteolin, and naringenin, 
respectively.  At 48 hr, the cell viabilities were 71.3% 50.3%, 53.75%, and 68.52% for 
chrysin, genistein, methyl-luteolin, and naringenin, respectively.  Daidzein was a weak 
killer at both 24 and 48 hr.  The cell viabilities were 76.9% and 87.7%, at 24 and 48 hr, 
respectively.  Catechin, myricetin, and methyl-naringenin did not induce cell death at 
either 24 or 48 hr. 
Intracellular Concentration of Flavonoids after 24 and 48 hr Incubation 
Based on the previous results, the next step was to determine the intracellular 
concentration of flavonoids.  After incubating MDA-MB-231 cells with different 
flavonoids, viable cells were counted and extracted with 40% MeOH.  The extracts were 
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injected into the LC-MS for analysis.  For most flavonoids, the amounts of compounds 
detected within cytosol were higher at 48 hr than at 24 hr (Fig. 8). 
	  
Fig. 8. The intracellular amount of flavonoid detected from cell extracts after 24 and 48 
hr. Reported values are in pmol per viable cell. 
 
We grouped the amount of flavonoid within viable cell into different categories.  
The amount that was considered high was more than 4 x 10-3 pmol per cell; moderate, 
pmol per cell ranged from 1.5 x 10-3 to 4 x 10-3; low, pmol per cell were less than 1 x 10-
3.  The amount of flavonoid within viable cells was high for methyl-apigenin, luteolin, 
and methyl-luteolin at both 24 and 48 hr.  For methyl-apigenin, 4.47 x 10-3 and 8.73 x 10-
3 pmol per cell were detected at 24 and 48 hr, respectively.  For luteolin, 4.22 x 10-3 and 
5.93 x 10-3 pmol per cell were detected at 24 and 48 hr, respectively.  For methyl-luteolin, 
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the amount was extremely high; 1.52 x 10-2 and 1.47 x 10-1 pmol per cell were detected at 
24 and 48 hr, respectively.  For kaempferol, the amount of flavonoid within cells was 
moderate at 24 hr and high at 48 hr; 2.66 x 10-3 and 4.07 x 10-3 pmol per cells were 
detected at 24 and 48 hr, respectively.	  	  The amount of flavonoid within cells was low at 
24 hr and moderate at 48 hr for chrysin; 1.04 x 10-3 and 2.74 x 10-3 pmol per cell were 
detected at 24 and 48 hr, respectively.  The amount of flavonoid within cells was low for 
apigenin, daidzein, naringenin, methyl-naringenin, methyl-quercetin, and genistein at 24 
and 48 hr.  At 24 hr, the amount of flavonoid detected was 8.02 x 10-4, 1.98 x 10-4, 3.50 
x10-4, 5.86 x 10-4, 3.02 x 10-4, and 1.18 x 10-4 pmol per cell for apigenin, daidzein, 
naringenin, methyl-naringenin, methyl-quercetin, and genistein, respectively.  At 48 hr, 
the amount of flavonoid detected was 9.21 x10-4, 2.54 x 10-4, 1.20 x 10-3, 1.06 x 10-3, 4.95 
x 10-4, and 1.14 x 10-4 pmol per cell for apigenin, daidzein, naringenin, methyl-
naringenin, methyl-quercetin, and genistein, respectively.  Catechin, myricetin, and 
quercetin were not detected within viable cells at either 24 or 48 hr. 
Flavonoid Stability in Cell Culture Medium 
Because we did not detect catechin, myricetin, and quercetin in our cell extracts, it 
prompted us to look at flavonoid stability in the medium over time.  We prepared 
flavonoids in the medium (no cells present) at 100 µM and monitored the levels at 0 and 
24 hr after incubation using LC-MS. Apigenin, methyl-apigenin, chrysin, daidzein, 
kaempferol, luteolin, methyl-luteolin, naringenin, methyl-naringenin, and methyl-
quercetin were stable in cell culture medium over time (Fig. 9).  The abundance of these 
flavonoids was stable after 24 hr.  Except for quercetin, catechin, and myricetin, these 
34	  
	  
flavonoids were not stable in cell culture medium over time (Fig. 10).  Catechin and 
quercetin could be detected at 0 hr but decreased over time.  Myricetin could not be 
detected in medium at any time point. 
 
	  
Fig.  9. Flavonoid relative ion counts at 0 and 24 hr in cell culture medium.  
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Fig. 10. Non-stable flavonoids in cell culture medium. Catechin (A), quercetin (B). 
 
Quercetin Dimerized in Cell Culture Medium 
 The amount of quercetin rapidly decreased after 24 hr in cell culture medium.  It 
was either degraded or modified.  Therefore, samples were analyzed using Agilent 
Masshunter Qualitative and MassProfiler software.  The MassProfiler identified all of the 
masses in the samples.  It compared the differences in masses between the 0 hr and 24 hr 
samples.  The MassProfiler identified a mass of 302.0427 unique to the 0 hr sample, and 
a mass of 602.0697 was unique to the 24 hr sample (Fig. 11).  A careful review of the 
literature reveals that a dimer of quercetin with the mass of 602.0797 is naturally present 
in onion (Ly et al., 2005) (Fig. 12). 
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Fig. 11. Detection of unique masses from 0 and 24 hr samples using Agilent MassProfiler 
software. Blue: compound unique to 0-hour sample. Red: unique to 24 hr sample. At the 
retention time of 2.7 min, the mass 302.0427, quercetin, is only present in the 0 hr 
sample. At the retention time of 6.7 min, the mass 602.0697, quercetin dimer, is only 
present in the 24 hr sample. 
	   	   	    
	   	   	   A	   	   	   	   	   	  	  	  	  B	  
Fig. 12. Molecular structure of quercetin (A) and a quercetin dimer (B) (Ly et al., 2005). 
Quercetin has a structure of C15H10O7 and a mass of 302.0427. Quercetin dimer has a 
structure of C30H18O14 and a mass of 602.0697. 
 
Quercetin and quercetin dimer were adequately separated by the HPLC column.  
Quercetin had a retention time of 2.6 min, and quercetin dimer had a retention time of 6.5 
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min.  The abundance of each compound was analyzed at 0, 6, and 24 hr. The results 
showed that the amount of quercetin dimer increased over the incubation period and the 
amount of quercetin decreased (Fig. 13). 
 
A	  
	  
B	  
Fig. 13. Chromatogram of quercetin and quercetin dimer after 0, 6, and 24 hr(A). 
Quercetin and quercetin dimer ion counts after 0, 6, and 24 hr (B). 
 
Quercetin Dimerized in the Presence of Fetal Bovine Serum 
Quercetin dimerized in complete medium, and we suspected this was due to 
protein(s) found in FBS.  An experiment was conducted to confirm this.  We prepared 
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two tubes that contained 100 µM quercetin in PBS supplemented with 10% (v/v) FBS.  
The difference between the tubes was that the second tube contained boiled FBS, 
denaturing the proteins.  Samples were collected at 0 and 24 hr, extracted, and analyzed 
by LC-MS.  Quercetin rapidly decreased, and the amount of quercetin dimer rapidly 
increased in the presence of normal FBS.  In the presence of boiled FBS, the amount of 
quercetin also decreased but at a slower rate, and the amount of quercetin dimer could be 
detected at 24 hr but with a much smaller amount than the sample in normal FBS (Fig. 
14). 
	  
Fig. 14. Quercetin and quercetin dimer after 24 hr in PBS with 10% normal FBS and PBS 
with 10% boiled FBS. 
 
Quercetin Dimerized in the Presence of Albumin 
 The most abundant protein in FBS is albumin.  Therefore, we tested purified 
albumin to determine if it caused the dimerization of quercetin.  Tube 1 contained 100 
µM quercetin in PBS.  Tube 2 contained 100 µM quercetin in PBS with 2.5 mg/ml BSA.  
Tube 3 contained 100 µM quercetin in PBS with 2.5 mg/ml actin.  Samples were 
collected, extracted, and analyzed by LC-MS at 0, 6 and 24 hr after incubation.  This 
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experiment was done at three different temperatures, 22oC (room temp), 4oC, and 37oC.  
In PBS without proteins, the amount of quercetin was temperature dependent.  Quercetin 
decreased with a high rate at 37oC and with a low rate at 4oC.  Quercetin dimer was not 
detected from the PBS-only sample.  In the presence of BSA, quercetin rapidly decreased 
with temperature dependence, and the amount of quercetin dimer rapidly increased with 
temperature dependence.  With BSA, quercetin decreased with a high rate at 37oC and 
with a low rate at 4oC; quercetin dimer increased with a high rate at 37oC and low rate at 
4oC.  In the presence of actin, quercetin decreased over time; however, the decrease was 
at a lower rate than with the other two samples.  The quercetin dimer was not detected in 
the presence of actin (Fig. 15). 
 
Fig. 15. Quercetin in PBS only (A), quercetin in PBS with BSA (B), quercetin in PBS 
with actin (C), and quercetin dimer in PBS with BSA (D). 
40	  
	  
Cell Viability is Based on the Status of Quercetin in Medium 
MDA-MB-231 cells were treated with two different quercetin media, fresh 100 
µM quercetin medium and 24 hr 100 µM quercetin medium.  The results were 
normalized to the DMSO treatment.  After 24 hr, the cell viabilities were 47.9% for cells 
treated with fresh 100 µM quercetin medium and 93.0% for cells treated with 24 hr 100 
µM quercetin medium (Fig. 16 A).  In the 24 hr 100 µM quercetin medium, quercetin 
modified into dimer; therefore, it could not induce cell death.  For control purposes, this 
experiment was repeated with kaempferol.  After 24 hr, the cell viabilities were 58.0% 
for cells treated with fresh 100 µM kaempferol medium, and 60.4% for cells treated with 
24 hr 100 µM kaempferol medium (Fig. 16 B). 
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Fig. 16. Cell viability of fresh flavonoids and 24 h-old flavonoids after 24 hr of treatment. 
Quercetin (A) and kaempferol (B). 
 
 MDA-MB-231 cells were treated with 100 µM quercetin medium at 0, 6, and 12 
hr.  Each time, cells were treated with freshly prepared 100 µM quercetin medium.  The 
cell viability was determined at 24 and 72 hr.  A single dose of quercetin was used for 
control.  The results were normalized to the DMSO treatment.  At 24 hr, the viable 
percentages were significantly different between a single-dose and multiple-dose 
treatment (p=0.01852).  The cell viabilities were 63.1% and 47.6% for a single-dose and 
multiple-dose treatment, respectively.  At 72 hr, the viable percentages were significantly 
different (p=0.000318), 20.9% and 8.1% for a single-dose and multiple-dose treatment, 
respectively (Fig. 17 A).  This suggests that quercetin from a single-dose treatment 
dimerized over time and did not induce cell death to the same degree as the multiple-dose 
treatment.  In the multiple-dose treatment, with the addition of fresh 100 µM quercetin 
media, the cytotoxicity was higher.  For control purposes, this experiment was repeated 
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with kaempferol.  At 24 hr, the viable percentages were significantly different between a 
single-dose and multiple-dose treatment.  The viable percentages were 46.1% and 28.2% 
for a single-dose and multiple-dose, respectively.  At 72 hr, the viable percentages were 
significantly different.  The viable percentages were 24.6% and 16.6% for a single-dose 
and multiple-dose, respectively (Fig. 17 B). 
 
Fig. 17. Percent cell viability compared between a single-dose treatment and multiple-
dose treatment. Cells were treated with 100 µM quercetin (A) or kaempferol (B). 
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Quercetin Dimer did not Induce Cell Death 
We sought to determine if the quercetin dimer was able to kill MDA-MB-231 
cells.  We synthesized quercetin dimer by performing quercetin oxidation with potassium 
ferricyanide (Gulsen, Makris, & Kefalas, 2007).  We used preparatory TLC to isolate 
quercetin dimer. The isolated dimer was analyzed by LC-MS, and the most abundant 
mass in the isolated sample was [M+H]+ 603.0769 m/z, which was the mass of quercetin 
dimer.  In addition, the isolated dimer was analyzed by proton NMR (CD3OD): 5.93, 
6.18, 6.40, 6.70, 7.09, 7.18, 7.23, 7.87, and 7.96 ppm.  These results were similar to the 
published data that proposed the structure of quercetin dimer, 1,3,11a-trihydroxy-9-
(3,5,7-trihydroxy-4H-1-benzopyran-4-on-2-yl)-5a-(3,4-dihydroxyphenyl)-5,6,11-
hexahydo-5,6,11-trioxanaphthacene-12-one (Ly et al., 2005).  This isolated quercetin 
dimer was dissolved in DMSO and treated to cells at 100 µM.  After 72 hr, the isolated 
quercetin dimer did not induce cell death (Fig. 18). 
	  
Fig. 18. Isolated quercetin dimer cytotoxicity on MDA-MB-231 cells after 72 hr. 
Quercetin killed and isolated quercetin dimer did not. Quercetin 100 µM viability was 
54.6%, and isolated quercetin dimer 100 µM viability was 99.4%. 
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Discussion 
 
Flavonoid Cytotoxicity and Intracellular Concentration on MDA-MB-231 Cells 
 Cell cytotoxicity and the amount of flavonoid found in MDA-MB-231 cell 
extracts varied between tested flavonoids.  For most of the tested flavonoids, the amount 
of the flavonoid found in cell extracts was higher after 48 hr of incubation.  The highest 
levels of flavonoid in cell extracts were seen with methyl-apigenin, kaempferol, and 
luteolin.  The lowest detectable levels were seen with daidzein, naringenin, and methyl-
naringenin.  The amount of flavonoid found within cells correlated with the amount of 
cell death at 24 and 48 hr.  For kaempferol, luteolin, and methyl-apigenin, the levels of 
flavonoids found within cells were high; therefore, the cell death percentages were also 
high at both 24 and 48 hr.  For daidzein, naringenin, and methyl-naringenin, the levels of 
flavonoids found within cells were low; therefore, the cell death percentages were low for 
these flavonoids.  For apigenin and methyl-quercetin, the levels of flavonoid found within 
cells were low; however, the cell death percentages were moderate.  Further investigation 
is needed for these flavonoids. 
Catechin, myricetin, and quercetin were not detected in cell extracts at either 24 
or 48 hr and, as expected, did not induce cell death.  Catechin and myricetin were not 
detected in cell culture medium, without cells, after 24 hr.  This suggests that these two 
flavonoids were rapidly degraded.  Yokomizo and Moriwaki (2005) reported that 
myricetin degraded immediately after addition in DMEM, and our results are in accord 
with this.  However, catechin degradation in DMEM should be investigated further.  
Quercetin was not detected intracellular and cell culture medium at 24 and 48 hr. 
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Interestingly, quercetin was able to induce cell death, 61.3% viable cells at 24 hr, and 
46.1% viable cells at 48 hr.  This suggests that quercetin was modified in cell culture 
medium. 
The flavonol class is the most abundant in nature as well as the most interesting.  
Each one of the tested flavonoids behaved differently.  Kaempferol’s ability to enter cells 
was high, methyl-quercetin’s was low, quercetin was modified over the incubation 
period, and myricetin rapidly degraded after addition to medium.  Kaempferol’s structure 
shows that flavonols’ structure has the ability to travel across MDA-MB-231 cell 
membrane.  The flavonol group has a double bond between carbons 2 and 3, which 
makes flavonoids planar, giving them a greater ability to enter cells.  This also suggests 
that myricetin, quercetin, and methyl quercetin should be able to enter cells well.  
However, the results from this thesis do not support this idea. 
Methyl-apigenin, chrysin, luteolin, and methyl-luteolin are in the subclass of 
flavones.  Flavonoids in this class were able to enter cells at a higher rate than others 
tested; methyl-luteolin had the highest concentration in cells.  The double bond between 
carbons 2 and 3 in the flavones group makes the structure planar, increasing the 
permeability of the cell. Methyl-luteolin entered cell at a much higher rate than luteolin.  
The methyl groups enhanced the cell membrane permeability for methyl-luteolin.  
However, the cytotoxicity of luteolin was much higher than methyl-luteolin.  This 
suggests that once a flavonoid enters cells, it must bind to the appropriate proteins to 
induce cell death. 
46	  
	  
Flavonoids from the flavanones class, naringenin and methyl-naringenin, entered 
cells at approximately the same rate.  This suggests that methylation does not enhance the 
cell membrane permeability for methyl-naringenin. The structure of flavanones is very 
similar to that of flavones, except for a single bond instead of a double bond between 
carbons 2 and 3.  This result shows that a flavonoid with a double bond between carbons 
2 and 3 has a better ability to travel across cell membranes than a flavonoid with a single 
bond.  
Daidzein and genistein, which are both in the isoflavones class, had the lowest 
concentration in cells of all flavonoids tested.  The structures of flavonoids in this class 
are different from the others.  Unlike other classes, the B ring is connected to carbon 
number 3 instead of carbon number 2.  This result shows that flavonoids with the B ring 
at carbon number 3 have lower membrane permeability than flavonoids with the B ring at 
carbon number 2. 
Some flavonoids with methyl ether groups, methyl-apigenin and methyl-luteolin, 
had a greater ability to enter a cell; this was not observed for methyl-naringenin and 
methyl-quercetin.  After 24 and 48 hr, the level of methyl-apigenin and methyl-luteolin 
found within cells was much higher than the level of apigenin and luteolin, respectively.  
Similar results have been reported in other studies (Walle et al., 2007; Wen et al., 2006).  
This suggests that the methyl groups enhance cell membrane permeability.  However, 
methyl-naringenin did not enter cells as well as the other methylated flavonoids.  Even 
though this flavonoid has methyl ether groups, it has a single bond between carbons 2 and 
3 indicating that this flavonoid is not planar.  Methyl-quercetin was also unable to 
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adequately enter cells.  According to the literature, with five additional methyl ether 
groups attached, methyl-quercetin should be able to enter cells easily.  This needs to be 
investigated further. 
Flavonoid Stability in Cell Culture Medium 
 Most of the flavonoids, with the exception of catechin, myricetin, and quercetin, 
were stable in cell culture medium.  This suggests that there was no loss of flavonoids 
during the period of incubation with cells.  After 24 hr in cell culture media, 37oC, and 
5% CO2, the amount of flavonoids remained the same; therefore, the activity remained 
the same as hour 0. 
 Catechin is most different of the tested flavonoids.  This structure does not have a 
ketone group on the three-carbon bridge.  In addition, this flavonoid has two chiral 
carbons.  These are the probable reasons catechin is unstable in cell culture medium. 
The stability of flavonoids in the flavonols class is not uniform.  Kaempferol and 
methyl-quercetin were stable within cell culture medium, myricetin rapidly degraded 
after addition to the medium, and quercetin dimerized in cell medium.  These flavonoids’ 
structures are very similar, yet dimerization only occurs in quercetin.  Quercetin has two 
hydroxyl groups on the B ring, where kaempferol and myricetin have one and three, 
respectively.  The dimerization is likely specific to flavonols with two hydroxyl groups 
on the B ring.  Alternatively, methyl-quercetin did not undergo dimerization.  The methyl 
groups probably block the dimerization process at the three-carbon bridge. 
Quercetin-3-O-glucopyranoside has a glucopyranoside group at carbon number 3 
instead of a hydroxyl group compared to quercetin (Fig. 19).  Quercetin-3-O-
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glucopyranoside did not dimerize in cell culture medium (data not shown).  This suggests 
that the dimerization of quercetin involves the three-carbon bridge.  In addition, 
quercetin-3-O-glucopyranosdie was not able to enter cells.  The glucopyranoside attached 
makes the structure bulky and polar, thus reducing the permeability into the cell 
membrane.  
	  
Fig. 19. Quercetin-3-O-glucopyranoside structure. 
Quercetin Dimerized in Cell Culture Medium 
 Quercetin was not detected by our method in cell extracts at any of the time points 
tested.  However, quercetin was able to induce cell death.  This suggests that quercetin 
was degraded or modified.  The stability of quercetin in cell culture medium was tested.  
The result showed that quercetin abundance decreased during incubation.  A new mass, 
602.0697, was only detected in the sample at hour 24.  That mass was almost double the 
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mass of quercetin, 302.0427.  In addition, quercetin was only detected in the hour 0 
sample.  Because of this, we suspected that dimerization of quercetin occurred during 
incubation with cell culture medium.  Quercetin was mixed with DMEM complete media 
and incubated for 24 hr.  Three different time points were collected from the solution, 0, 
6, and 24 hr, for LC-MS analysis.  The results showed that dimerization was time 
dependent.  The lowest level of quercetin dimer detected was at 0 hr, and the highest 
level was at 24 hr. 
As suggested in the literature, quercetin dimerizes at the hydroxyl group on 
carbon number 3.  To confirm this structure, quercetin-3-O-glucopyranoside was 
incubated in cell culture medium.  After 24 hr, no dimer was detected (data not shown).  
The glucopyranoside group was replaced with the hydroxyl group at carbon 3 on 
quercetin.  This blocked the oxidation process at this location; therefore, quercetin was 
not able to dimerize in cell culture media.  This suggests that dimerization of quercetin 
occurs at carbon number 3. 
Quercetin Dimerization 
Quercetin only dimerized in medium with FBS; it did not dimerize in medium 
without FBS.  Because globular protein, bovine serum albumin (BSA), is a major 
component of FBS, it is logical to assume that albumin is the cause for quercetin 
dimerization.  Results show that in the presence of albumin, quercetin dimerized over 
time.  Quercetin is oxidized to products that can covalently bind to albumin (Kaldas et al., 
2005).  This dimerization is unique to quercetin and no other flavonoid in that same class.  
This suggests that dimerization requires hydroxyl groups at carbon numbers 3, 3’ and 4’.  
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Kaempferol cannot undergo dimerization because it is missing a hydroxyl group at 
carbon 3’; myricetin cannot undergo dimerization because it has an extra hydroxyl group 
at carbon 5’; methyl-quercetin cannot undergo dimerization because it has the methyl 
groups. 
Quercetin Dimer did not Induce Cell Death 
Results from the experiment using 24 hr-old quercetin medium showed that 
quercetin left in the media could no longer induce cell death.  This suggested to us that 
the dimerized form of quercetin could not kill cells.  In addition, the result from the 
single-dose versus multiple-dose treatment showed that when fresh quercetin was added, 
cells died at a higher rate.  The quercetin added from later doses replaced the original that 
had already dimerized in cell culture media.  This shows that fresh quercetin was able to 
induce cell death until it dimerized. 
We do not know whether quercetin has the ability to enter cells.  We were not 
able to detect any quercetin or quercetin dimer in cells after 24 hr.  However, the results 
from the synthesized quercetin dimer showed that it did not have the ability to enter cells 
and did not induce cell death. 
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